Harbour BioMed, a cancer therapies company has acquired Harbour Antibodies from Erasmus MC Holding, Atlas Holding and other shareholders. Harbour Antibodies focuses on the production of antibodies and VH (heavy chain with one variable) domains for therapy. With this acquisition, Harbour BioMed plans to expand its presence in the Boston area by establishing a drug discovery innovation centre.
Mergers & Acquisitions. 15 / 08 2021
VIOTTA advised Management and Workers on acquisition of Panteia B.V. from Stichting Panteia
VIOTTA advised Panteia B.V. with the acquisition by the management and Workers together with Nimbus Stichting Panteia. Panteia provides policy research & consultancy and market research services for small andVIEW CASE